Trainline Raises Annual Guidance for Second Time in 2026 Inflations Broadening Beyond Oil and Iran These Sectors Show Reaccelerating Price Pressures Top Economists Forecast Inflation to Reach 6 in Q2 Amid Persistent Price Pressures SpaceX Successfully Launches Starship in Second Attempt Advancing HeavyLift Capabilities Companies Maintain Prediction Market Investments Amid Regulatory Uncertainty Barclays Analyzes Market Implications of Embodied AI Bullish or Bearish BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus DOW Q1 2026 Earnings EPS Beats Estimates by 5176 Despite Narrowing Loss CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance Senseonics Holdings Inc SENS Q1 2026 Earnings Slight EPS Miss but Modest Stock Gains Amid Continued RD Focus UWMC Q1 2026 Earnings EPS Surprises to the Upside as Mortgage Market Stabilizes Coffee Holding Co JVA Edges Higher Holds Above Key Support Level Eaton Vance TaxManaged Diversified Equity Income Fund ETY Edges Higher Amid Cautious Trading LiqTech International LIQT Edges Lower as Resistance Level Holds Firm Offerpad Solutions OPAD Rallies 77 to 075 Testing Key Resistance Near 079 Willamette Valley Vineyards WVVI Holds Steady at 267 as Key Support and Resistance Levels Narrow Indias Consumer Affairs Ministry Probes Cancellation Policies of Online Ticket Platforms OpenAI Takes the Lead in AI IPO Race Confidential Filing Expected Soon Trump Administrations 2 Billion Quantum Computing Investment Implications for IBM DWave and Rigetti AI Disruption Triggers Decline in Vendor Satisfaction Among Channel Partners Dollar Holds Near SixWeek High as Geopolitical Tensions Over Iran Stir Demand for Safe Havens Kevin Hassett Highlights Surge in Credit Card Spending Amid Rising Delinquencies and Farm Bankruptcies Market Expectations Shift Toward Fed Rate Hike After Hot Inflation Data EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization Rapport Therapeutics RAPP Hovers Near Support Tests Key Level After Mild Decline